Anesthetic considerations of percutaneous transcatheter aortic valve implantation: first attempt in Korea -A report of 2 cases-
Korean Journal of Anesthesiology 2011³â 60±Ç 2È£ p.128 ~ p.133
¼ÕÈ¿Á¤(Son Hyo-Jung) - University of Ulsan College of Medicine Department of Anesthesiology and Pain Medicine
ÀÌȹÌ(Lee Hwa-Mi) - University of Ulsan College of Medicine Department of Anesthesiology and Pain Medicine
ÁøÁöÇö(Chin Ji-Hyun) - University of Ulsan College of Medicine Department of Anesthesiology and Pain Medicine
ÃÖ´ë±â(Choi Dae-Kee) - University of Ulsan College of Medicine Department of Anesthesiology and Pain Medicine
ÀÌÀºÈ£(Lee Eun-Ho) - University of Ulsan College of Medicine Department of Anesthesiology and Pain Medicine
½ÉÁö¿¬(Sim Ji-Yeon) - University of Ulsan College of Medicine Department of Anesthesiology and Pain Medicine
ÃÖÀÎö(Choi In-Cheol) - University of Ulsan College of Medicine Department of Anesthesiology and Pain Medicine
Abstract
Conventional aortic valve replacement for severe aortic stenosis is associated with a high operative mortality in the elderly patients with significant comorbidities, including severe respiratory dysfunction, renal insufficiency, and compromised cardiac function. Human transcatheter aortic valve implantation was first reported in 2002 and has become a valid alternative in selected high-risk patients in Europe and North America. This article describes the first attempt of transfemoral transcatheter aortic valve implantation in Korea. The procedure was applied in two consecutive patients with severe aortic stenosis. Despite several intra-operative complications during procedure, the post-operative outcomes were good for both patients. At post-operative 30 days there was satisfactory prosthetic valve function and hemodynamic stability.
Å°¿öµå
Anesthesia, Aortic stenosis, Conventional aortic valve replacement, Percutaneous transcatheter aortic valve implantation
KMID :
0356920110600020128
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
The post-operative outcomes were good for both patients. At post-operative 30 days there was satisfactory prosthetic valve function and hemodynamic stability; TAVI has become an alternative to surgical AVR for the elderly with comorbidities who have a high operative mortality rate or are deemed non-operable.